Roche has bolstered its R&D pipeline in oncology and neuroscience with a pair of partnerships with Orionis Biosciences and PeptiDream, parting with upfront cash of $87 million for projects in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback